Detalhe da pesquisa
1.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood
; 142(17): 1438-1447, 2023 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418685
2.
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
Blood
; 134(10): 798-801, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292118
3.
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.
Am J Hematol
; 95(2): 151-155, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31709579
4.
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Br J Haematol
; 183(5): 755-765, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407629
5.
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry.
Hematol Oncol
; 33(3): 147-51, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777784
6.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Blood Adv
; 8(6): 1541-1549, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181782
7.
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions.
Hematol Oncol
; 31(2): 72-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23027689
8.
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.
Haematologica
; 101(5): e196-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26858355
9.
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma.
Leuk Lymphoma
; 57(4): 880-7, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26379040
10.
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study.
Leuk Lymphoma
; 56(12): 3281-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25791121
11.
Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin.
Mediterr J Hematol Infect Dis
; 6(1): e2014048, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25045456
12.
Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.
Leuk Lymphoma
; 54(1): 53-7, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22712840
13.
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy.
Leuk Lymphoma
; 52(9): 1689-96, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21663500
14.
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
Hematol Oncol
; 25(4): 189-97, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17654762
15.
Purification and characterization of heparin from the Italian clam Callista chione.
Biomacromolecules
; 6(3): 1672-8, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15877393
16.
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
Glycobiology
; 14(12): 1275-84, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15253929